Literature DB >> 8816294

Reversal of CNS-prophylaxis-related leukoencephalopathy after CSF shunting: case histories of identical twins.

I H Tekkök1, D A Carter, M G Robinson, R Brinker.   

Abstract

We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation. The delayed encephalopathy developed 9 and 22 months respectively after the first dose of intrathecal methotrexate. Both patients underwent cerebrospinal fluid shunting mainly for their hydrocephalus. The imaging studies have shown that both hydrocephalus and leukoencephalopathy have improved significantly after ventriculoperitoneal shunt insertion. We review the pathophysiology of prophylaxis-related encephalopathy in leukemia patients and summarize its clinical, histological, and radiological characteristics. We also discuss the possible contribution of altered cerebrospinal fluid dynamics in the development of leukoencephalopathy.

Entities:  

Mesh:

Year:  1996        PMID: 8816294     DOI: 10.1007/bf00301018

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  Encephalopathy in acute leukaemia associated with methotrexate therapy.

Authors:  H E Kay; P J Knapton; J P O'Sullivan; D G Wells; R F Harris; E M Innes; J Stuart; F C Schwartz; E N Thompson
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

2.  Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia.

Authors:  D Gangji; G H Reaman; S R Cohen; W A Bleyer; D G Poplack
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

3.  Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.

Authors:  J C Allen; G Rosen
Journal:  Ann Neurol       Date:  1978-05       Impact factor: 10.422

4.  CT abnormalities and altered methotrexate clearance in children with CNS leukemia.

Authors:  P K Duffner; M E Cohen; M L Brecher; P Berger; K L Parthasarathy; S Bakshi; L J Ettinger; A Freeman
Journal:  Neurology       Date:  1984-02       Impact factor: 9.910

5.  Computerized tomography scan findings in children with acute lymphocytic leukemia treated with three different methods of central nervous system prophylaxis.

Authors:  M L Brecher; P Berger; A I Freeman; J Krischer; J Boyett; A S Glicksman; E Foreman; M Harris; B Jones; M E Cohen
Journal:  Cancer       Date:  1985-11-15       Impact factor: 6.860

6.  Serial cranial computed-tomography scans in children with leukemia given two different forms of central nervous system therapy.

Authors:  J J Ochs; L S Parvey; J N Whitaker; W P Bowman; L Ch'ien; M Campbell; T Coburn
Journal:  J Clin Oncol       Date:  1983-12       Impact factor: 44.544

7.  Neurologic sequelae of methotrexate and ionizing radiation: a new classification.

Authors:  W A Bleyer
Journal:  Cancer Treat Rep       Date:  1981

8.  Enhancement of the white matter following prophylactic therapy of the central nervous system for leukemia: radiation effects and methotrexate leukoencephalopathy.

Authors:  P R Shalen; P T Ostrow; P J Glass
Journal:  Radiology       Date:  1981-08       Impact factor: 11.105

9.  Computer assisted tomography in methotrexate encephalopathy.

Authors:  N Peylan-Ramu; D G Poplack; C L Blei; J R Herdt; M Vermess; G Di Chiro
Journal:  J Comput Assist Tomogr       Date:  1977-04       Impact factor: 1.826

10.  Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.

Authors:  L J Rubinstein; M M Herman; T F Long; J R Wilbur
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.